Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Micron’s Explosive Growth Meets Wall Street’s Highest Target Yet as Supply Tightens Into 2027

Kennethcix by Kennethcix
May 20, 2026
in Uncategorized
0
Micron Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

Micron delivered a 756% leap in earnings per share to $12.07 in its fiscal second quarter, yet the stock ended Monday at $681.54, down nearly 6% on heavy volume. That contradiction – between operational firepower and market skepticism – sets the stage for the company’s appearance at the J.P. Morgan Global Technology, Media and Communications Conference in Boston. Investors want to know whether the AI-driven memory boom can sustain its momentum without tripping over cyclical fears or geopolitical landmines.

Analysts are not waiting for an answer. Melius Research nearly doubled its price target to $1,100 from $700, labeling Micron a “bottleneck stock” that stands to gain from structural shortages in semiconductor capacity. Mizuho followed with an increase to $800 from $740, maintaining an “Outperform” rating. Both firms see DRAM and NAND pricing holding firm deep into 2027, underpinned by AI data centers, HBM memory, and enterprise SSDs. Mizuho also points to a new “High Bandwidth Flash” product that could further tighten NAND supply in two years.

The supply picture received an unexpected boost – or averted blow – from South Korea. Samsung Electronics and its union reached a tentative agreement hours before a planned 18-day strike that would have disrupted production at the memory giant. Samsung controls roughly 40% of the global DRAM market and 30% of NAND flash. TrendForce had estimated that even a partial walkout could take 3% to 4% of worldwide DRAM output offline, accelerating order shifts to competitors like Micron and SK Hynix. The deal still requires ratification by 48,000 union members between May 22 and 27, so the risk has not entirely evaporated.

Should investors sell immediately? Or is it worth buying Micron?

Regardless of the Samsung drama, the fundamental story for Micron is one of sold-out capacity. Analysts note that the three largest memory makers have essentially no spare production slots left for 2026, and early customers are already negotiating contracts for 2027. Mizuho projects Micron’s revenue will grow 66% in fiscal 2027 and earnings per share will surge 80% year-over-year. The company’s own guidance for the current quarter calls for $33.5 billion in revenue – a 260% jump – and $18.90 in earnings per share.

China remains the sensitive undercurrent. Micron generated about $3.4 billion in revenue from the country last year, roughly 12% of total sales. The company has exited the domestic Chinese data center business but continues to serve Chinese clients with data centers abroad. Meanwhile, capital expenditures are slated to rise to $20 billion in fiscal 2026, up from an earlier estimate of $18 billion, as Micron secures capacity for next-generation HBM and advanced DRAM fabrication.

The next major milestone is the fiscal third-quarter earnings report due on June 24. Wall Street expects earnings of $19.15 per share, up from $1.91 a year earlier, on revenue of $33.51 billion. The conference in Boston gives management a chance to address the questions that drove the recent pullback: whether HBM capacity can remain fully utilized, how DRAM pricing will evolve, and how the company plans to navigate its exposure to China. For now, the stock trades around €619 in Frankfurt – more than seven times its 52-week low – and has added over 130% since the start of the year. The market may be testing the valuation, but the supply constraints supporting it show no signs of easing.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from June 14 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

Micron: Buy or sell? Read more here...

Tags: Micron
Kennethcix

Kennethcix

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

June 14, 2026
BMW Stock
Automotive & E-Mobility

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock
Analysis

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Next Post
Siemens Energy Stock

Siemens Energy Nears First Buyback Limit as Saudi Mega-Plants Begin Operations

BYD Stock

BYD's Fangchengbao Reaches 400,000 Vehicles as Profit Slump and Shareholder Exit Cast a Shadow

ServiceNow Stock

ServiceNow’s Dramatic Re-rating: How a 38% Plunge Sparked a Bullish Stampede

Recommended

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

5 months ago
Blackrock Stock

BlackRock’s Global Strategy: Dividend Payouts and Market Expansion

9 months ago
D-Wave Quantum Stock

D-Wave Quantum: A Story of High Ambition Amidst Financial Crosscurrents

3 months ago
Ooma Stock

Ooma Stock: A Clash Between Analyst Optimism and Insider Selling

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

OHB’s Free Float Squeeze Nears a Release as KKR Exit and Rocket Flight Converge

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

by Rodolfo Hanigan
June 14, 2026
0

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a...

BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026
Amazon Stock

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans
  • Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com